Remove Food and Drug Administration Remove Leads Remove Manufacturing Remove Side effects
article thumbnail

Developing a first-in-class small molecule drug for inflammatory disease

European Pharmaceutical Review

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

article thumbnail

The internet enables misinformation on COVID

World of DTC Marketing

In some instances, vaccine-hesitant activists are manufacturing stories of deaths related to the vaccine that never happened. While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. But it’s a bet that seems to have paid off.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Three-dose vaccine prevents HIV patients getting hepatitis B

European Pharmaceutical Review

The most common side effects related to vaccination were injection site pain, malaise, fatigue, muscle aches and headaches. The international study will continue to examine the effects of two-dose HEPLISAV-B. It will also evaluate ENGERIX-B, a GSK-manufactured three-dose hepatitis B vaccine series.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

In this exclusive discussion with EPR , Dr Jack Hoppin, CEO, and Dr John Babich, Chief Scientific Officer of Ratio Therapeutics share their perspective on the evolving radiopharmaceutical landscape, including the challenges of manufacturing these cancer treatments and why radiopharmaceutical therapeutics are so promising for this widespread disease.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”. The CAR T cells need to persist in the blood to expand and elicit maximal effect, and there is a correlation between expansion and persistence and response.

article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

You know, in November 2009, the FDA held a public hearing about the promotion of Food and Drug Administrative Related Regulated Medical Products, using the internet and social media tools. They would write up the presentations by physicians about drugs. But you’d have to have one click to the side effects.

Media 52
article thumbnail

Pharma coming to moral crossroads

World of DTC Marketing

Will it lead to an early approval with limited testing or will J&J ensure the vaccine goes thru thorough testing? government to manufacture 100 million doses of its investigational COVID-19 vaccine. OK, NOW WHAT? J&J’s COVID vaccine is being promoted by the media to have a 98% immune system response.